Nsai

Safety Partners, founded in 1992, specializes in delivering bespoke environmental health and safety (EHS) programs tailored for life science and technology companies. With expertise in regulatory compliance, industrial hygiene, and lab relocation, they ensure that operations not only meet safety standards but also thrive efficiently. By leveraging the unique science backgrounds of their consulting officers, Safety Partners provides guidance that addresses the specific needs of diverse clients, from startups to established enterprises. Their commitment to ongoing professional development and EHS training underscores their role as a vital resource in the life science industry across the nation. Generated from the website

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company's primary focus is on receiving contingent milestone payments from the sale of ONIVYDE to Ipsen S.A. in April 2017. Operating without any ongoing research or development activities, Merrimack Pharmaceuticals utilizes external consultants for its operations and does not have any employees. The company's business model centers around its entitlement to milestone payments and strategic partnerships within the biopharmaceutical industry.Generated from the website